. . . "Our findings not only show promising therapeutic potential for resolution of neovascular AMD, but also for other conditions or diseases that involve angiogenesis and inflammation, such as atherosclerosis and cancer, said Kip Connor, Ph.D., Assistant Professor in Ophthalmology at Harvard Medical School and senior author of the paper." . .